Belenox brings an expert, analytical viewpoint on key decisions related to supply chain management and operations. Providing alternative protocol design recommendations, reducing the overall operational costs of the end-to-end supply chain, providing specific training, advising on the choice of technologies are just examples of missions Belenox is involved in.
Adapting the supply chain processes, implementing software solutions, or even adapting a protocol to better account for supply chain impacts, may lead to savings of a few million dollars on a single trial.
Clients include bio/pharma companies of any size, but also service and software providers, worldwide.
Founder
Cédric Druck
Cédric is the Founder, CEO and CTO of Trialzen. He has worked in clinical trial supply forecasting and planning since 2005, combining a background in applied mathematics with nearly two decades of experience developing and implementing forecasting solutions across the industry.
Prior to founding Trialzen, Cédric contributed to the development of clinical supply technologies at N-SIDE and 4G Clinical, working closely with sponsors and CROs to address complex supply chain challenges in global trials.
He founded Trialzen to bring rigorous modeling, modern technology, and practical usability to clinical supply planning. His focus is on helping teams anticipate risks earlier, reduce waste, and make faster, more confident decisions in clinical development.
He now leads the AI transformation at Trialzen and speaks regularly on applied AI in clinical supply, including GCSG AI boot camps and an ISPE session on using agentic AI to build clinical supply tools.